IXICO PLC Share Price London S.E.
Equities
GB00BCLY7L40
Biotechnology & Medical Research
Sales 2024 * | 52L 66.24L 55Cr | Sales 2025 * | - | Capitalization | 33.85L 43.12L 36Cr |
---|---|---|---|---|---|
Net income 2024 * | -20L -25.48L -21Cr | Net income 2025 * | - | EV / Sales 2024 * | 0.38 x |
Net cash position 2024 * | 14L 17.83L 15Cr | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.17% |
Latest transcript on IXICO PLC
Managers | Title | Age | Since |
---|---|---|---|
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 06/17/06 |
Director of Finance/CFO | 47 | 31/19/31 | |
Charles Spicer
CHM | Chairman | 59 | 14/13/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 14/13/14 |
Director/Board Member | 49 | 16/16/16 | |
Dipti Amin
BRD | Director/Board Member | 60 | 05/23/05 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr |